-
1
-
-
0036840676
-
Small animal imaging: Current technology and perspectives for oncological imaging
-
J.S. Lewis, S. Achilefu, J.R. Barbow, R. Laforest, M.J. Welch. "Small animal imaging: current technology and perspectives for oncological imaging." Eu J Cancer 38, 2173-2188, 2002.
-
(2002)
Eu J Cancer
, vol.38
, pp. 2173-2188
-
-
Lewis, J.S.1
Achilefu, S.2
Barbow, J.R.3
Laforest, R.4
Welch, M.J.5
-
2
-
-
0034646351
-
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
-
V. Ntziachristos, A.G. Yodh, M. Schnall, B. Chance. "Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement." Proc Natl Acad Sci USA 97, 2767-2772, 2000.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 2767-2772
-
-
Ntziachristos, V.1
Yodh, A.G.2
Schnall, M.3
Chance, B.4
-
3
-
-
0030854535
-
Optical imaging of breast tumor by means of continuous waves
-
S. Nioka, Y. Yung, M. Shnall, S. Zhao, S. Orel, C. Xie, B. Chance, L Solin. "Optical imaging of breast tumor by means of continuous waves. " Adv Exp Med Biol 411, 227-232, 1997.
-
(1997)
Adv Exp Med Biol
, vol.411
, pp. 227-232
-
-
Nioka, S.1
Yung, Y.2
Shnall, M.3
Zhao, S.4
Orel, S.5
Xie, C.6
Chance, B.7
Solin, L.8
-
4
-
-
0031183895
-
Fluorescence and absorption contrast mechanisms for biomedical optical imaging using frequency-domain techniques
-
E.M. Sevick-Muraca, G. Lopez, J.S. Reynolds, T.L. Troy, C.L. Hutchinson. "Fluorescence and absorption contrast mechanisms for biomedical optical imaging using frequency-domain techniques." Photochem Photobiol 66, 55-64, 1997.
-
(1997)
Photochem Photobiol
, vol.66
, pp. 55-64
-
-
Sevick-Muraca, E.M.1
Lopez, G.2
Reynolds, J.S.3
Troy, T.L.4
Hutchinson, C.L.5
-
5
-
-
9444287591
-
Carcinoembryonic antigen expression, antibody localization and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy
-
C.A. Vogel, M.C. Galmiche, P. Westermann, L.Q. Sun, A. Pelegrin, S. Folli, A. Bischof Delaloye, D.O. Slosman, F. Buchegger. "Carcinoembryonic antigen expression, antibody localization and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy." Int J Cancer 67, 294-302, 1996.
-
(1996)
Int J Cancer
, vol.67
, pp. 294-302
-
-
Vogel, C.A.1
Galmiche, M.C.2
Westermann, P.3
Sun, L.Q.4
Pelegrin, A.5
Folli, S.6
Delaloye, A.B.7
Slosman, D.O.8
Buchegger, F.9
-
6
-
-
0031239968
-
Tumor detection and visualization using cyanine fluorochromelabeled antibodies
-
B. Ballou, G.W. Fisher, T.R. Hakala, D.L. Farkas. "Tumor detection and visualization using cyanine fluorochromelabeled antibodies. Biotechnology Prog 13, 649-658, 1997.
-
(1997)
Biotechnology Prog
, vol.13
, pp. 649-658
-
-
Ballou, B.1
Fisher, G.W.2
Hakala, T.R.3
Farkas, D.L.4
-
7
-
-
0028225314
-
Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice
-
S. Folli, P. Westermann, D. Braichotte, A. Pelegrin, G. Wagnieres, H. van den Bergh, J.P. Mach. "Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice." Cancer Res 54, 2643-2649, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 2643-2649
-
-
Folli, S.1
Westermann, P.2
Braichotte, D.3
Pelegrin, A.4
Wagnieres, G.5
Van Den Bergh, H.6
Mach, J.P.7
-
8
-
-
0031958762
-
Cyanine fluorochrome-labeled antibodies in vivo: Assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7
-
B. Ballou, G.W. Fisher, J.S. Deng, T.R. Hakala, M. Srivastava, D.L. Farkas. "Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect Prev 22, 251-257, 1998.
-
(1998)
Cancer Detect Prev
, vol.22
, pp. 251-257
-
-
Ballou, B.1
Fisher, G.W.2
Deng, J.S.3
Hakala, T.R.4
Srivastava, M.5
Farkas, D.L.6
-
9
-
-
0028824432
-
Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies
-
B. Ballou, G.W. Fisher, A.S. Waggoner, D.L. Farkas, J.M. Reiland, R. Jaffe, R.B. Mujumdar, S.R. Mujumdar, T.R. Hakala. "Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies." Cancer Immunol Immunother 41, 257-263, 1995.
-
(1995)
Cancer Immunol Immunother
, vol.41
, pp. 257-263
-
-
Ballou, B.1
Fisher, G.W.2
Waggoner, A.S.3
Farkas, D.L.4
Reiland, J.M.5
Jaffe, R.6
Mujumdar, R.B.7
Mujumdar, S.R.8
Hakala, T.R.9
-
10
-
-
0035297578
-
Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform
-
J.E. Bugaj, S.Achilefu, R.B.Dorshow. "Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform." J. Biomedical Optics 6, 122-133, 2001.
-
(2001)
J. Biomedical Optics
, vol.6
, pp. 122-133
-
-
Bugaj, J.E.1
Achilefu, S.2
Dorshow, R.B.3
-
11
-
-
0023637601
-
New perspectives in cell adhesion: RGD and integrins
-
Ruoslahti, E. and Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins. Science (Wash. DC), 238, 491-497, 1987.
-
(1987)
Science (Wash. DC)
, vol.238
, pp. 491-497
-
-
Ruoslahti, E.1
Pierschbacher, M.D.2
-
12
-
-
0034698147
-
Ligand binding to integrins
-
E.F. Plow, T.A. Haas, L. Zhang, J Loftus, J.W. Smith. "Ligand binding to integrins." J. Biol. Chem., 275, 21785-21788, 2000.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 21785-21788
-
-
Plow, E.F.1
Haas, T.A.2
Zhang, L.3
Loftus, J.4
Smith, J.W.5
-
13
-
-
0037372226
-
αv Vitronectin receptors in vascular-mediated disorders
-
S.A. Mousa. "αv Vitronectin Receptors in Vascular-Mediated Disorders." Medicinal Research Reviews, 23, 190-199, 2003.
-
(2003)
Medicinal Research Reviews
, vol.23
, pp. 190-199
-
-
Mousa, S.A.1
-
14
-
-
0001254182
-
Integrins: Structure, function and biological properties
-
D. Cheresh. "Integrins: Structure, function and biological properties." Ad Mol Cell Biol. 6, 225-252, 1993.
-
(1993)
Ad Mol Cell Biol.
, vol.6
, pp. 225-252
-
-
Cheresh, D.1
-
15
-
-
0034698147
-
Ligand binding to integrins
-
E.F. Plow, T.A. Haas, L. Zhang, J. Loftus, J.W. Smith. "Ligand binding to integrins." J Biol Chem, 275, 21785-21788, 2000.
-
(2000)
J Biol Chem
, vol.275
, pp. 21785-21788
-
-
Plow, E.F.1
Haas, T.A.2
Zhang, L.3
Loftus, J.4
Smith, J.W.5
-
16
-
-
0033121275
-
The role of αv integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
-
B.P. Eliceiri, and D.A. Cheresh, D.A. "The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development." J Clin Invest, 103, 1227-1230, 1999.
-
(1999)
J Clin Invest
, vol.103
, pp. 1227-1230
-
-
Eliceiri, B.P.1
Cheresh, D.A.2
-
17
-
-
0028362876
-
Requirement of vascular integrin αvβ3 for angiogenesis
-
P.C. Brooks, R.A.F. Clark, DA. Cheresh. "Requirement of vascular integrin αvβ3 for angiogenesis." Science (Wash.), 264, 569-571, 1994.
-
(1994)
Science (Wash.)
, vol.264
, pp. 569-571
-
-
Brooks, P.C.1
Clark, R.A.F.2
Cheresh, D.A.3
-
18
-
-
0026683840
-
Expression and modulation of vitronectin receptor on human dermal microvascular endothelial cells
-
R.A. Swerlick, E.J. Brown, Y. Xu, K.H. Lee, S. Manos, T.J. Lawley. "Expression and modulation of vitronectin receptor on human dermal microvascular endothelial cells." J Invest Dermatol. 99, 715-722. 1993.
-
(1993)
J Invest Dermatol.
, vol.99
, pp. 715-722
-
-
Swerlick, R.A.1
Brown, E.J.2
Xu, Y.3
Lee, K.H.4
Manos, S.5
Lawley, T.J.6
-
19
-
-
0035254648
-
Angiogenesis: Regulators and clinical applications
-
S. Liekens, E. De Clercq, J. Neyts, "Angiogenesis: regulators and clinical applications." Biochem Pharmacol. 61, 253-270, 2001.
-
(2001)
Biochem Pharmacol.
, vol.61
, pp. 253-270
-
-
Liekens, S.1
De Clercq, E.2
Neyts, J.3
-
20
-
-
0028972105
-
Anti-integrin αvβ3 blocks human breast cancer growth, and angiogenesis in human skin
-
P.C. Brooks, S. Stromblad, R. Klemke, D. Visscher, F.H. Sarkar, D.A. Cheresh. "Anti-integrin αvβ3 blocks human breast cancer growth, and angiogenesis in human skin." J Chin Invest, 96, 1815- 1822, 1995.
-
(1995)
J Chin Invest
, vol.96
, pp. 1815-1822
-
-
Brooks, P.C.1
Stromblad, S.2
Klemke, R.3
Visscher, D.4
Sarkar, F.H.5
Cheresh, D.A.6
-
21
-
-
0028670833
-
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
-
P.C. Brooks, A. M. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier, D.A. Cheresh. "Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels." Cell 79, 1157-1164, 1994.
-
(1994)
Cell
, vol.79
, pp. 1157-1164
-
-
Brooks, P.C.1
Montgomery, A.M.2
Rosenfeld, M.3
Reisfeld, R.A.4
Hu, T.5
Klier, G.6
Cheresh, D.A.7
-
22
-
-
0033998223
-
In vitro and in vivo effects of a cyclic peptide with affinity for the αvβ3 integrin in human melanoma cells
-
R. Allman, P. Cowburn, P., M. Mason,. "In vitro and in vivo effects of a cyclic peptide with affinity for the αvβ3 integrin in human melanoma cells." Eur J Cancer 36, 410-422, 2000.
-
(2000)
Eur J Cancer
, vol.36
, pp. 410-422
-
-
Allman, R.1
Cowburn, P.2
Mason, M.3
-
23
-
-
0035122334
-
Glycosylated RGD-containing peptides: Tracer for tumor targeting and angiogenesis imaging with improved biokinetics
-
R. Haubner, H.J. Wester, F. Burkhart, R. Senekowitsch-Schmidtke, W. Weber, S.L. Goodman, H. Kessler, M. Schwaiger. "Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics." J Nucl Med. 42, 326-336, 2001.
-
(2001)
J Nucl Med.
, vol.42
, pp. 326-336
-
-
Haubner, R.1
Wester, H.J.2
Burkhart, F.3
Senekowitsch-Schmidtke, R.4
Weber, W.5
Goodman, S.L.6
Kessler, H.7
Schwaiger, M.8
-
24
-
-
0033859533
-
Evaluation of a radiolabeled cyclic DPTA-RGD analogue for tumor imaging and radionuclide therapy
-
P.M. Van Hagen, W. A. Breeman, H.R. Bernard, M. Schaar, C.M. Mooij, A. Srinivasan, MA. Schmidt, E. P. Krenning, M. de Jong. "Evaluation of a radiolabeled cyclic DPTA-RGD analogue for tumor imaging and radionuclide therapy." Int J Cancer 90, 186-198, 2000.
-
(2000)
Int J Cancer
, vol.90
, pp. 186-198
-
-
Van Hagen, P.M.1
Breeman, W.A.2
Bernard, H.R.3
Schaar, M.4
Mooij, C.M.5
Srinivasan, A.6
Schmidt, Ma.7
Krenning, E.P.8
De Jong, M.9
-
25
-
-
7344231683
-
Imaging of metastatic melanoma utilizing a technetium-99m labeled RGD-containing synthetic peptide
-
G.B. Sivolapenko,D. Skarlos, D. Pectasides, E. Stathopoulou, A. Milonakis, G. Sirmalis, A. Stattle, N.S. Courtenay Luck, K. Konstantinides, A. A. Epenetos. "Imaging of metastatic melanoma utilizing a technetium-99m labeled RGD-containing synthetic peptide." Eur J Nucl Med 25, 1383-1389, 1998.
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 1383-1389
-
-
Sivolapenko, G.B.1
Skarlos, D.2
Pectasides, D.3
Stathopoulou, E.4
Milonakis, A.5
Sirmalis, G.6
Stattle, A.7
Luck, N.S.C.8
Konstantinides, K.9
Epenetos, A.A.10
-
26
-
-
0032587186
-
Radiolabeled αvβ3 integrin antagonists: A new class of tracers for tumor targeting
-
R. Haubner, H.J. Wester, U. Reuning, R. Senekowitsch Schmidtke, B. Diefenbach, H. Kessler, G. Stocklin, M. Schwaiger. "Radiolabeled αvβ3 integrin antagonists: a new class of tracers for tumor targeting." J Nucl Med. 40, 1061-1071, 1999.
-
(1999)
J Nucl Med.
, vol.40
, pp. 1061-1071
-
-
Haubner, R.1
Wester, H.J.2
Reuning, U.3
Senekowitsch Schmidtke, R.4
Diefenbach, B.5
Kessler, H.6
Stocklin, G.7
Schwaiger, M.8
-
27
-
-
0035266374
-
18F-labeled RGD-containing glycopeptide and positron emission tomography
-
18F-labeled RGD-containing glycopeptide and positron emission tomography." Cancer Res. 61, 1781-1785, 2000.
-
(2000)
Cancer Res.
, vol.61
, pp. 1781-1785
-
-
Haubner, R.1
Wester, H.J.2
Weber, W.A.3
Mang, C.4
Ziegler, S.L.5
Goodman, S.L.6
Senekowitsch-Schmidtke, R.7
Kessler, H.8
Schwaiger, M.9
-
28
-
-
0036829759
-
Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model
-
M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens, O.C. Boerman. "Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model." Cancer Res. 62, 6146-6151, 2002.
-
(2002)
Cancer Res.
, vol.62
, pp. 6146-6151
-
-
Janssen, M.L.1
Oyen, W.J.2
Dijkgraaf, I.3
Massuger, L.F.4
Frielink, C.5
Edwards, D.S.6
Rajopadhye, M.7
Boonstra, H.8
Corstens, F.H.9
Boerman, O.C.10
-
29
-
-
0033853378
-
Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging
-
S. Achilefu, R.B. Dorshow, J.E. Bugaj, R. Rajagopalan. "Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging." Invest Radial. 35, 479-485, 2000.
-
(2000)
Invest Radial.
, vol.35
, pp. 479-485
-
-
Achilefu, S.1
Dorshow, R.B.2
Bugaj, J.E.3
Rajagopalan, R.4
-
30
-
-
0037046519
-
Vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents
-
Achilefu, S., Jimenez, H.N., Dorshow, R.B., Bugaj, J.E., Webb, E.G., Wilhelm, R.R., Rajagopalan, R., Johler, J. and Erion, J.L. Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J. Med. Chem. 45: 2003-2015.
-
J. Med. Chem.
, vol.45
, pp. 2003-2015
-
-
Achilefu, S.1
Jimenez, H.N.2
Dorshow, R.B.3
Bugaj, J.E.4
Webb, E.G.5
Wilhelm, R.R.6
Rajagopalan, R.7
Johler, J.8
Erion, J.L.S.9
|